<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607566</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT008830</org_study_id>
    <nct_id>NCT02607566</nct_id>
  </id_info>
  <brief_title>Yoga as a Complementary Therapy for Adults With Type 2 Diabetes</brief_title>
  <official_title>Yoga as a Complementary Therapy for Type 2 Diabetes: An Initial Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Miriam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Massachusetts, Lowell</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Miriam Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the feasibility and acceptability of a twice weekly yoga program for
      adults with type 2 diabetes. Changes in perceived stress, salivary cortisol, and HbA1c will
      also be examined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the current proposal is to test a yoga intervention for adults with T2DM and
      to gather data on the feasibility and acceptability of yoga compared to a contact control for
      glycemic control. The investigators will conduct a pilot randomized controlled study with
      participants randomly assigned to 1) Yoga intervention, or 2) A standard exercise (SE) group
      program (comparison-control). Focus groups will be conducted with participants at the end of
      the intervention to identify facilitators and barriers to yoga practice and to examine their
      perceptions and beliefs about yoga and its relationship to stress and diabetes management.
      The investigators will explore the effect of yoga on stress (biomarker = salivary cortisol)
      that may act as a mechanism of action underlying the efficacy of yoga for improved glycemic
      control. The investigators will also measure HbA1c levels, fasting and postprandial plasma
      glucose at baseline, end of treatment (12-weeks), 6- and 9-month follow-ups. Study
      feasibility and acceptability will be assessed using participant recruitment, attendance and
      retention rates, and compliance with study protocols and satisfaction with the program.
      Participants will also attend a focus-group discussion of the program at the end of
      treatment. Results from this study will provide scientific basis for a future larger clinical
      trial. Yoga, if found to offer advantages for glycemic control, can have potential for high
      impact on current practices of diabetes management.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability as measured by session attendance</measure>
    <time_frame>12 weeks</time_frame>
    <description>Number of sessions attended</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility as measured by study completion</measure>
    <time_frame>6 months</time_frame>
    <description>Percent of enrolled subjects completing all assessments</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in diabetes-related distress as measured by Diabetes Related Distress Survey</measure>
    <time_frame>Baseline to Week 12</time_frame>
    <description>Percent change in score on the Diabetes Related Distress Survey (Polonsky et al., 1995)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Salivary Cortisol (ug/dL) between baseline and week 12</measure>
    <time_frame>Baseline to Week 12</time_frame>
    <description>Saliva samples collected at baseline and week 12 will be assayed for cortisol levels (ug/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>6 months</time_frame>
    <description>HbA1c levels from blood draws</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Self-Care</measure>
    <time_frame>12 weeks</time_frame>
    <description>Surveys of diabetes related self care activities</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Iyengar Yoga</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iyengar Yoga Intervention twice weekly for 60 minutes for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Exercise Program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>professionally supervised program of aerobic exercise including use of an indoor walking track, treadmills, stationary bicycles and elliptical machines, held for 60 minutes twice weekly for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Yoga</intervention_name>
    <arm_group_label>Iyengar Yoga</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Exercise Program</intervention_name>
    <description>twice weekly aerobic exercise program, 60 minutes for 12 weeks</description>
    <arm_group_label>Standard Exercise Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes for more than 6 months

          -  HbA1c &gt; 6.5

          -  Body Mass Index &lt; 42

        Exclusion Criteria:

          -  Serious co-morbid condition (e.g. uncontrolled hypertension, glaucoma, heart failure)

          -  Complications of diabetes (e.g. diabetic retinopathy, neuropathy, nephropathy)

          -  Serious psychiatric disorder (e.g. psychosis, major depression, panic attacks,
             suicidality, or substance dependence)

          -  Body Mass Index of 42 or greater

          -  Pregnancy or planned pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beth Bock, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Miriam Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Miriam Hospital- CORO building</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Thind H, Fava JL, Guthrie KM, Stroud L, Gopalakrishnan G, Sillice M, Gidron N, Bock BC. Yoga as a Complementary Therapy for Adults with Type 2 Diabetes: Design and Rationale of the Healthy, Active, and in Control (HA1C) Study. Int J Yoga Therap. 2018 Nov;28(1):123-132. doi: 10.17761/2018-00026. Epub 2018 Aug 21.</citation>
    <PMID>30130144</PMID>
  </reference>
  <results_reference>
    <citation>Thind H, Guthrie KM, Horowitz S, Conrad M, Bock BC. &quot;I can do almost anything&quot;: The experience of adults with type 2 diabetes with a yoga intervention. Complement Ther Clin Pract. 2019 Feb;34:116-122. doi: 10.1016/j.ctcp.2018.11.011. Epub 2018 Nov 16.</citation>
    <PMID>30712714</PMID>
  </results_reference>
  <results_reference>
    <citation>Bock BC, Thind H, Fava JL, Dunsiger S, Guthrie KM, Stroud L, Gopalakrishnan G, Sillice M, Wu W. Feasibility of yoga as a complementary therapy for patients with type 2 diabetes: The Healthy Active and in Control (HA1C) study. Complement Ther Med. 2019 Feb;42:125-131. doi: 10.1016/j.ctim.2018.09.019. Epub 2018 Sep 26.</citation>
    <PMID>30670230</PMID>
  </results_reference>
  <results_reference>
    <citation>Thind H, Lantini R, Balletto BL, Donahue ML, Salmoirago-Blotcher E, Bock BC, Scott-Sheldon LAJ. The effects of yoga among adults with type 2 diabetes: A systematic review and meta-analysis. Prev Med. 2017 Dec;105:116-126. doi: 10.1016/j.ypmed.2017.08.017. Epub 2017 Sep 4. Review.</citation>
    <PMID>28882745</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <study_first_submitted>November 12, 2015</study_first_submitted>
  <study_first_submitted_qc>November 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>April 23, 2019</last_update_submitted>
  <last_update_submitted_qc>April 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Yoga</keyword>
  <keyword>Walking</keyword>
  <keyword>Stress</keyword>
  <keyword>exercise</keyword>
  <keyword>glycemic control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

